Shanghai - Delayed Quote
CNY
Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)
15.03
-0.27
(-1.76%)
At close: 3:00:00 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Yi Jiang Mei
|
President & Director | -- | -- | 1975 |
|
Mr. Yujie Sha
|
VP, Financial Director & Director | -- | -- | 1980 |
|
Mr. Huilu Lin
|
VP, Secretary of the Board of Directors & Director | -- | -- | 1973 |
|
Dr. Yuanqiang Li
|
VP & Director | -- | -- | 1967 |
|
Mr. Nonggang Yang
|
Vice President | -- | -- | 1975 |
|
Ms. Minxia Huang
|
Vice President | -- | -- | 1976 |
|
Mr. Gong Chen
|
Vice President | -- | -- | 1982 |
|
An Wu
|
Accounting Supervisor | -- | -- | -- |
Zhejiang Jiuzhou Pharmaceutical Co., Ltd
No. 99 Waisha Road
Jiaojiang District
Taizhou, 318000
China
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 4,791
Description
Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecules, drug products, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and scientific research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.
Corporate Governance
Zhejiang Jiuzhou Pharmaceutical Co., Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
September 11, 2026 at 12:00 AM UTC
Ex-Dividend Date
